• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".

作者信息

Tai Wei-Tien, Cheng Ann-Lii, Shiau Chung-Wai, Huang Hsiang-Po, Huang Jui-Wen, Chen Pei-Jer, Chen Kuen-Feng

机构信息

National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Molecular Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

National Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

J Hepatol. 2017 Mar;66(3):666-668. doi: 10.1016/j.jhep.2016.12.007. Epub 2017 Jan 6.

DOI:10.1016/j.jhep.2016.12.007
PMID:28069352
Abstract
摘要

相似文献

1
Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".《“信号转导和转录激活因子3是索拉非尼在肝细胞癌中的主要非激酶作用靶点”的勘误》
J Hepatol. 2017 Mar;66(3):666-668. doi: 10.1016/j.jhep.2016.12.007. Epub 2017 Jan 6.
2
Erratum to: Corrigendum to "Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma".《“信号转导与转录激活因子3是索拉非尼在肝细胞癌中的主要非激酶作用靶点”的勘误说明》的勘误
J Hepatol. 2017 Jun;66(6):1334-1335. doi: 10.1016/j.jhep.2017.02.021. Epub 2017 Mar 13.
3
Downregulation of signal transducer and activator of transcription 3 by sorafenib: a novel mechanism for hepatocellular carcinoma therapy.索拉非尼对信号转导和转录激活因子3的下调作用：一种肝细胞癌治疗的新机制。
World J Gastroenterol. 2014 Nov 7;20(41):15269-74. doi: 10.3748/wjg.v20.i41.15269.
4
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma.信号转导子和转录激活子 3 是索拉非尼在肝细胞癌中主要的激酶非依赖性靶标。
J Hepatol. 2011 Nov;55(5):1041-8. doi: 10.1016/j.jhep.2011.01.047. Epub 2011 Feb 24.
5
Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.索拉非尼诱导的HIF-2α上调通过激活肝癌细胞中的TGF-α/EGFR途径导致耐药。
Cell Signal. 2014 May;26(5):1030-9. doi: 10.1016/j.cellsig.2014.01.026. Epub 2014 Jan 29.
6
Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma.从索拉非尼中发现新型Src 同源结构域 2 结构域含磷酶 1 激动剂，用于治疗肝细胞癌。
Hepatology. 2014 Jan;59(1):190-201. doi: 10.1002/hep.26640. Epub 2013 Dec 9.
7
Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.索拉非尼通过 MEK/ERK 信号通路增强人肝癌细胞系 SMMC-7721 的放射敏感性。
Int J Radiat Biol. 2013 Sep;89(9):724-31. doi: 10.3109/09553002.2013.791405. Epub 2013 May 31.
8
Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells.诱导 DNA 损伤诱导基因 GADD45β 有助于索拉非尼诱导肝癌细胞凋亡。
Cancer Res. 2010 Nov 15;70(22):9309-18. doi: 10.1158/0008-5472.CAN-10-1033. Epub 2010 Nov 9.
9
Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.索拉非尼下调 HTATIP2 的表达，促进原位肝癌小鼠肿瘤的侵袭和转移。
Gastroenterology. 2012 Dec;143(6):1641-1649.e5. doi: 10.1053/j.gastro.2012.08.032. Epub 2012 Aug 23.
10
The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.多激酶抑制剂索拉非尼可诱导对甲磺酸伊马替尼高度耐药的bcr/abl+人白血病细胞凋亡，这与信号转导和转录激活因子5的抑制以及髓样细胞白血病-1的下调有关。
Mol Pharmacol. 2007 Sep;72(3):788-95. doi: 10.1124/mol.106.033308. Epub 2007 Jun 26.

引用本文的文献

1
Shp1 in Solid Cancers and Their Therapy.实体癌中的Shp1及其治疗
Front Oncol. 2020 Jun 11;10:935. doi: 10.3389/fonc.2020.00935. eCollection 2020.